SOAT1 and neoplasm: As the preclinical studies have shown, JAK/STAT signaling is tremendously complex, and, while on balance, constitutive activation tends to promote tumor proliferation, angiogenesis, and immune escape, the effects of targeting upstream or downstream effectors are not always predictable.